Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novelion Therapeutics Inc (NQ: NVLN )

0.6800 USD UNCHANGED
Last Price Updated: 4:35 PM EDT, Oct 8, 2019 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.6800
Bid (Size) 0.6300 (14)
Ask (Size) 1.110 (12)
Prev. Close 0.6800
Today's Range 0.6800 - 0.6800
52wk Range N/A - N/A
Shares Outstanding 18,558,072
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Novelion Therapeutics Announces Nasdaq Delisting
From GlobeNewswire News Releases
Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters
From GlobeNewswire News Releases

Performance

More News

Read More
Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers
From GlobeNewswire News Releases
Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Annual General Meeting of Shareholders
From GlobeNewswire News Releases
Novelion Therapeutics Provides Update Regarding Delisting from Nasdaq and Aegerion Bankruptcy Case
From GlobeNewswire News Releases
Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq
From GlobeNewswire News Releases
Novelion Therapeutics Announces Anticipated Late Filing of Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2019
From GlobeNewswire News Releases
Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition
From GlobeNewswire News Releases
Novelion Therapeutics Receives Delisting Notifications
From GlobeNewswire News Releases
Novelion Therapeutics Responds to Whitefort Capital Petition
From GlobeNewswire News Releases
Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which Amryt Pharma Plc Will Acquire 100% of Reorganized Stock of Aegerion
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.